相关实验视频
Updated: Jul 5, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
破坏RNA结合蛋白IMP3通过破坏E2F5转录的稳定性来抑制口腔状细胞癌的扩散
Zhenzhen Wang1, Huahua Zhang2, Fang Li3
1Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Aging
|January 25, 2024
概括
胰岛素样生长因子2mRNA结合蛋白3 (IMP3) 通过稳定E2F5mRNA促进口腔状细胞癌 (OSCC),影响细胞增殖. 针对IMP3/E2F5可能为OSCC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在各种癌症中,RNA结合蛋白 (RBPs) 的调节失调,包括口腔状细胞癌 (OSCC).
- 胰岛素样生长因子2 mRNA结合蛋白3 (IMP3) 在OSCC进展中起作用,但其调节机制尚不清楚.
- 了解IMP3在mRNA命运中的作用对于开发向疗法至关重要.
研究的目的:
- 调查OSCC中IMP3介导的E2F5表达的IMP3调节的分子机制.
- 为了确定IMP3/E2F5轴在OSCC进展中的功能意义.
- 评估IMP3/E2F5作为OSCC的潜在治疗点.
主要方法:
- 在OSCC组织和细胞系中分析IMP3和E2F5表达的分析,使用免疫组织化学,qRT-PCR和西白斑.
- 在OSCC细胞系 (SCC-25,SCC-4) 中使用siRNA抑制IMP3表达.
- RNA免疫沉 (RIP) 试验以确认IMP3与E2F5mRNA结合.
- 在体外和体内 (异种移植小鼠模型) 的功能研究.
主要成果:
- 在OSCC中观察到IMP3和E2F5表达之间的正相关性.
- IMP3直接与E2F5mRNA结合,调节其稳定性和蛋白质表达.
- 沉默IMP3导致E2F5水平降低,抑制细胞增殖,并在体内减少瘤生长.
- 在OSCC中,IMP3和E2F5参与调节细胞增殖和细胞循环.
结论:
- IMP3调节E2F5mRNA的稳定性,影响OSCC中的细胞增殖和细胞周期.
- IMP3/E2F5通路是OSCC进展的一个关键机制.
- IMP3和E2F5代表了口腔状细胞癌的有希望的治疗点.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K

